跳至主要内容
临床试验/JPRN-jRCT1051220039
JPRN-jRCT1051220039招募中未知

Efficacy and safety of aspirin in patients with chronic coronary syndromes without revascularization - ASA-IN study

Yamamoto Erika0 个研究点目标入组 2,890 人开始时间: 2022年6月9日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
2,890

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients with chronic coronary syndromes who have more than 50 percent diameter stenosis in one or more major coronary vessels/major branches, but are not eligible for revascularization

排除标准

  • History of ACS
  • History of PCI or CABG
  • Patients with left main trunk stenosis
  • Patients for whom aspirin administration is mandatory
  • Patients undergoing antithrombotic therapy other than aspirin
  • History of stroke within 6 months
  • Patients scheduled for major surgical procedures that will require aspirin discontinuation
  • Patients with contraindication of aspirin
  • Patients expected to have a prognosis of 1 year or less due to comorbidities
  • Women of child-bearing potential or women who have a positive pregnancy test at enrollment or randomization
  • Patients who are not appropriate for the participation in the study

研究者

发起方
Yamamoto Erika

相似试验